Jodi Akin, founder and CEO of Hawthorne Effect, discusses what comes next for the clinical trials company following a Series A funding round of $20 million.
BUSINESS
Hawthorne Effect Raises $20 Million Series A to Decentralize Clinical Trials
Jodi Akin, founder and CEO of Hawthorne Effect, discusses what comes next for the clinical trials company following a Series A funding round of $20 million.